Teladoc Health (NYSE:TDOC) Sets New 1-Year Low – Here’s What Happened

Teladoc Health, Inc. (NYSE:TDOC)’s stock price hit a new 52-week low on Tuesday . The company traded as low as $6.01 and last traded at $6.1150, with a volume of 2542150 shares traded. The stock had previously closed at $6.29.

Analyst Upgrades and Downgrades

A number of analysts have commented on the stock. Evercore ISI decreased their price target on shares of Teladoc Health from $9.00 to $8.00 and set an “in-line” rating for the company in a research note on Thursday, October 30th. Citigroup reduced their price objective on shares of Teladoc Health from $10.00 to $9.00 and set a “neutral” rating for the company in a report on Friday, January 9th. Barclays assumed coverage on shares of Teladoc Health in a report on Tuesday, December 9th. They issued an “equal weight” rating and a $8.50 target price on the stock. BMO Capital Markets began coverage on Teladoc Health in a research note on Thursday, November 13th. They set a “market perform” rating and a $8.00 price target for the company. Finally, Weiss Ratings reissued a “sell (e+)” rating on shares of Teladoc Health in a report on Monday, December 29th. Three equities research analysts have rated the stock with a Buy rating, twelve have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $9.12.

Teladoc Health Stock Performance

The stock has a market cap of $1.01 billion, a PE ratio of -4.45 and a beta of 2.04. The company’s 50 day simple moving average is $7.08 and its 200 day simple moving average is $7.61. The company has a debt-to-equity ratio of 0.71, a quick ratio of 2.60 and a current ratio of 2.70.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings results on Wednesday, October 29th. The health services provider reported ($0.21) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.26) by $0.05. The company had revenue of $626.44 million for the quarter, compared to the consensus estimate of $625.66 million. Teladoc Health had a negative net margin of 8.84% and a negative return on equity of 10.59%. The firm’s quarterly revenue was down 2.2% on a year-over-year basis. During the same period in the previous year, the firm earned ($0.19) EPS. Analysts expect that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

Insider Activity at Teladoc Health

In other Teladoc Health news, insider Adam C. Vandervoort sold 5,720 shares of the business’s stock in a transaction on Tuesday, December 2nd. The stock was sold at an average price of $7.49, for a total value of $42,842.80. Following the sale, the insider directly owned 80,732 shares in the company, valued at $604,682.68. The trade was a 6.62% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Fernando M. Rodrigues sold 4,209 shares of the stock in a transaction on Wednesday, December 3rd. The stock was sold at an average price of $7.48, for a total value of $31,483.32. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders sold 33,288 shares of company stock worth $251,684. Company insiders own 0.58% of the company’s stock.

Institutional Investors Weigh In On Teladoc Health

Several institutional investors have recently added to or reduced their stakes in the business. IFP Advisors Inc raised its position in shares of Teladoc Health by 412.1% in the third quarter. IFP Advisors Inc now owns 3,989 shares of the health services provider’s stock valued at $31,000 after purchasing an additional 3,210 shares during the period. Aster Capital Management DIFC Ltd grew its stake in Teladoc Health by 101.1% in the 3rd quarter. Aster Capital Management DIFC Ltd now owns 4,823 shares of the health services provider’s stock valued at $37,000 after buying an additional 2,425 shares in the last quarter. Bayforest Capital Ltd bought a new stake in Teladoc Health during the 3rd quarter valued at $58,000. KBC Group NV lifted its position in shares of Teladoc Health by 88.3% during the fourth quarter. KBC Group NV now owns 9,632 shares of the health services provider’s stock worth $67,000 after acquiring an additional 4,516 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd boosted its holdings in shares of Teladoc Health by 8,192.0% in the second quarter. Caitong International Asset Management Co. Ltd now owns 8,292 shares of the health services provider’s stock worth $72,000 after acquiring an additional 8,192 shares during the period. 76.82% of the stock is owned by hedge funds and other institutional investors.

About Teladoc Health

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.